Skip to the page

Data / Form D filings / Neurofold Therapeutics Inc.

Neurofold Therapeutics Inc.: Form D filing

Neurofold Therapeutics Inc., a biotechnology company in Greenwood Village, CO, filed a Form D with the SEC in 2026. The latest, on July 14, 2026, reports $6.5 million sold of a $6.5 million offering to 18 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
5500 S. MARIGOLD COURT, Greenwood Village, CO, 80121
Phone
(303) 564-8817
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2145237

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 14, 2026New notice$6,499,987$6,499,98718Jun 25, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Rajeev KumarExecutive Officer, Director
Gurdane BhutaniDirector

Other biotechnology companies in Colorado that filed recently

Every Form D from the week of Jul 13, 2026 · All recent filings in Colorado · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Neurofold Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.